Aplidin increases sensitivity to treatment in leukemia and lymphoma cells.

Authors
Journal	Expert review of anticancer therapy (Expert Rev Anticancer Ther) Vol. 3 Issue 2 Pg. 133-4 (Apr 2003) ISSN: 1473-7140 [Print] England
PMID	12722872 (Publication Type: News)
Chemical References	Antineoplastic Agents Depsipeptides Peptides, Cyclic plitidepsin
Topics	Antineoplastic Agents (pharmacology) Depsipeptides Drug Screening Assays, Antitumor Humans Peptides, Cyclic (pharmacology) Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!